Onconetix, Inc. Pension Cost (Reversal of Cost)
Onconetix, Inc. (ONCO) reported Pension Cost (Reversal of Cost) of -$48.42 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-06-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PensionExpense · last filed 2025-06-02
- Onconetix, Inc. pension cost (reversal of cost) for the quarter ending 2024-12-31 was -$64.92K.
- Onconetix, Inc. pension cost (reversal of cost) for the quarter ending 2024-09-30 was $41.37K.
- Onconetix, Inc. pension cost (reversal of cost) for the quarter ending 2024-06-30 was $33.54K.
- Onconetix, Inc. pension cost (reversal of cost) for the quarter ending 2024-03-31 was -$58.40K.
- Onconetix, Inc. pension cost (reversal of cost) for fiscal 2024 was -$48.42K, a 448.99% decline from fiscal 2023.
- Onconetix, Inc. pension cost (reversal of cost) for fiscal 2023 was $13.88K.
| Period end | Pension Cost (Reversal of Cost) 3 month | Pension Cost (Reversal of Cost) 6 month | Pension Cost (Reversal of Cost) 9 month | Pension Cost (Reversal of Cost) 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$64.92K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | -$23.55K derived: sum of 2 quarters · filed 2025-06-02 | $9.98K derived: sum of 3 quarters · filed 2025-06-02 | -$48.42K 10-K · filed 2025-06-02 |
| 2024-09-30 | $41.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | $74.91K derived: sum of 2 quarters · filed 2024-12-10 | $16.50K 10-Q · filed 2024-12-10 | |
| 2024-06-30 | $33.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-29 | -$24.87K 10-Q · filed 2024-08-29 | ||
| 2024-03-31 | -$58.40K 10-Q · filed 2024-05-20 | |||
| 2023-12-31 | $13.88K 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |